Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anderson H (2000) Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome. Br J Cancer 83: 447–453, 10.1054/bjoc.2000.1307
De Deyn P and D’Hooge R (1996) Placebos in clinical practice and research. J Med Ethics 22: 140–146
Slevin M (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses and general public. Br Med J 300: 1458–1460
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Farrugia, D., Lewis, R. Chemotherapy and quality of life in advanced NSCLC. Br J Cancer 85, 137 (2001). https://doi.org/10.1054/bjoc.2001.1851
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1851